Sex differences in the pivotal MS clinical trials: what is the evidence?

被引:0
|
作者
Bove, R. [1 ]
Houtchens, M. [2 ]
机构
[1] Univ Calif San Francisco, Neurol, Sandler Neurosci Ctr, UCSF Neurol, San Francisco, CA 94143 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P926
引用
下载
收藏
页码:503 / 503
页数:1
相关论文
共 50 条
  • [1] Baseline and longitudinal sex differences in 2465 patients in the placebo arms of pivotal trials for MS (MSOAC)
    Bove, R.
    Krishnakumar, T.
    Goldman, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 617 - 617
  • [2] Outcome differences by sex in oncology clinical trials
    Kammula, Ashwin V.
    Schaffer, Alejandro A.
    Rajagopal, Padma Sheila
    Kurzrock, Razelle
    Ruppin, Eytan
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] Outcome differences by sex in oncology clinical trials
    Kammula, Ashwin V.
    Schaffer, Alejandro A.
    Rajagopal, Padma Sheila
    Kurzrock, Razelle
    Ruppin, Eytan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] What Can We Learn from Sex Differences in MS?
    Coyle, Patricia K.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (10):
  • [5] Subgroup analysis in clinical trials: Detecting sex differences
    Greenberger, PE
    Knab, S
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (01): : 7 - 9
  • [6] Exercise and Weight Loss: What Is the Evidence of Sex Differences?
    Hagobian T.A.
    Evero N.
    Current Obesity Reports, 2013, 2 (1) : 86 - 92
  • [7] Physiological basis for sex differences in MS damage: MRI evidence
    Digiovanni, Anna
    Mascali, Daniele
    Chiarelli, Antonio
    Lipp, Ilona
    Grasso, Eleonora
    Pozzilli, Valeria
    Rispoli, Marianna Gabriella
    Villani, Alessandro
    D'Apolito, Maria
    Tomassini, Valentina
    Wise, Richard G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [8] THE LENA SYSTEM IN CLINICAL TRIALS: EVIDENCE FROM PIVOTAL RESPONSE TREATMENT STUDIES
    Hardan, Antonio
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S302 - S302
  • [9] Level of Evidence for FDA Drug Approvals in Pivotal Clinical Trials of Hematological Malignancies
    Al Hadidi, Samer
    Ramos, Carlos A.
    BLOOD, 2020, 136
  • [10] Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies
    Al Hadidi, Samer
    Ramos, Carlos Almeida
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1522 - 1524